Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

Jul 24, 2014

Early Warning of Any Cancer

Immunosignature analysis, a multiplexed means of profiling circulating antibodies, reveals patterns unique to specific cancers.

Early Warning of Any Cancer

Immunosignaturing could enable early cancer detection and deliver universality—a single platform could be used for any cancer. [Biodesign Institute, Arizona State University]

  • The reductionist approach to cancer detection—scrutinizing a particular set of biomarkers for each cancer—is fraught with obstacles. It may not be possible, in many ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »